Q2QLH0 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid6s6cibjdxei7qwnt2a4pwvouvmrgad4s532e2jusmtxqq7utor4/metadata.json
IPFS of structure file: 
bafybeidqj55ypg53lwxar2xjoyqwx6yt2w436kyxfdsxwmbi5c7d4dousa/AF-Q2QLH0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x37D23f42Fd2ebF3427de09E6ff9245a4403a5797
First NFT owner address (bech32): 
genesis1xlfr7sha96lngf77p8n0lyj953qr54uhqxtzft
Current NFT ID #58985 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
58985
Accession (UniProt):
Q2QLH0
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
OTOLEMUR GARNETTII

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2QLH0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2QLH0|CFTR_OTOGA Cystic fibrosis transmembrane conductance regulator OS=Otolemur garnettii OX=30611 GN=CFTR PE=3 SV=1 MQRSPLEKASVFSKLFFSWTRPILRKGYRQRLELSDIYQIPSADSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGILLYLGEVTKAVQPLLLGRIIASYDPDNKVERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKILKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVTLLMGLLWELLQASAFCGLGFLIVLALVQAGLGRMMMKYRDQRAGKINERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGIGELFEKAKQNNDNRKISNGDNSLFFSNLALLGAPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLRPDFSSKLMGFDSFDQFSAERRNSILTETLRRFSLEGDAAVSRNETKKQSFKQTGEIGEKRKNSILNPINSIRKFSVVQKTPLPMNGIDEEDSEEPVERRLSLVPDSEQGEAILPRSNVFNTGPTFQGRRRQSVLNLMTHSVNQGQNIHRKTAASTRKMSLAPQANLTEMDIYSRRLSQESSLEISEEINEEYLKECFCDDVENIPAVTTWNTYLRYLAVNKSLSLVLIWCLVIFLAEVAISLAVLLLLDKSPRYSKGNGTASGNGSSAVIITSTSSYYLFYIYVGVADTLLALGFFRGLPLVHTLITVSKILHHRMLHSVLRAPMSTLNMLKAGGILNRFSKDIAILDDLLPLTIFDFVQLLLIVIGAVAVVSVLQPYIFLATVPVIAAFVILRGYFLHTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVVFFIAVTFISILTTGEGEGTVGIILTLAMNIMGTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEEGRSTKSIKPSKDCQLSKVMIFENLHVKKDDIWPSGGQMTVKDLTARYIDSGNAILENISFSISPGQRVGLLGRTGAGKSTLLSAFLRLLNTEGDIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGYVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPITYQIIRRTLKQAFADCTVILCEHRIEAMLECQRFLVIEENKVRQYDSIQKLLSEKSLFRQAISPSDRMKLFPRRNSSKHKSRSPITALKEETEEEVQETRL